EPO Patents = 1

Forward Citations = 4

Loading Chart...

2 inventors (with patents filed for the assignee):

Weizhen Wang (5 out of 5 patents)

David Frederick Woodward (5 out of 113 patents)

5 patents: Sort by Forward Citations

1. 12478593 - Formulations for hair growth (2025-11-25),

2. 11857537 - Use of prostacyclin antagonists for treating ocular surface nociception (2024-01-02),

3. 11478437 - Formulations for hair growth (2022-10-25),

4. 9827225 - Use of prostacyclin antagonists for treating ocular surface nociception (2017-11-28),

5. 9820954 - Quantitative peri-orbital application of ophthalmology drugs (2017-11-21),

Company Overview

Jenivision Inc. is a leading provider of cutting-edge vision technology solutions for various industries. We specialize in developing state-of-the-art imaging systems for medical, industrial, and commercial applications. With a team of highly skilled engineers and designers, we strive to deliver innovative products that enhance the quality and efficiency of our clients' operations. Our commitment to excellence and customer satisfaction sets us apart in the industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#458 in Irvine, CA

#12,073 in California

#51,644 in US

Irvine, CA, United States of America

Jenivision Inc.

Forward Citations = 4

2 inventors:

Weizhen Wang (5 out of 5 patents)

David Frederick Woodward (5 out of 113 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Jenivision Inc.. Retrieved from https://idiyas.com/company/jenivision

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]